Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Pediatric and Adult Patients with or without Identified Genetic Complement Mutations or Complement Factor H Autoantibodies

Autor: Cataland, Spero R, Feldkamp, Thorsten *, Bedrosian, Camille L., Kincaid, John *, Minetti, Enrico E. *
Zdroj: In Blood 6 December 2014 124(21):2789-2789
Databáze: ScienceDirect